QSAR study of anticoccidial activity for diverse chemical compounds: prediction and experimental assay of trans-2-(2-nitrovinyl)furan.

In this work we report a QSAR model that discriminates between chemically heterogeneous classes of anticoccidial and non-anticoccidial compounds. For this purpose we used the Markovian Chemicals in silico Design (MARCH-INSIDE) approach J. Mol. Mod.2002, 8, 237-245; J. Mol. Mod.2003, 9, 395-407]. Linear discriminant analysis allowed us to fit the discriminant function. This function correctly classifies 86.67% of anticoccidial compounds and 96.23% of inactive compounds in the training series. Overall classification is 94.12%. We validated the model by means of an external predicting series, with 86.96% of global predictability. Remarkably, the present model is based on topological as well as configuration-dependent molecular descriptors. Therefore, the model performs timely calculations and allows discrimination between Z/E and chiral isomers. Finally, to exemplify the use of the model in practice we report the prediction and experimental assay of trans-2-(2-nitrovinyl)furan. It is notable that lesion control was 72.86% at mg/kg of body weight with respect to 60% at 125 mg/kg for amprolium (control drug). The back-projection map for this compound predicts a high level of importance for the double bond and for the nitro group in the trans position. We conclude that the MARCH-INSIDE approach enables the accurate fast track identification of anticoccidial hits. Moreover, trans-2-(2-nitrovinyl)furan seems to be a promising drug for the treatment of coccidiosis.

[1]  Alexander Golbraikh,et al.  Novel ZE-Isomerism Descriptors Derived from Molecular Topology and Their Application to QSAR Analysis , 2002, J. Chem. Inf. Comput. Sci..

[2]  Maykel Pérez González,et al.  A topological sub-structural approach for predicting human intestinal absorption of drugs. , 2004, European journal of medicinal chemistry.

[3]  M. Pybus,et al.  Parasitic diseases of wild mammals , 2001 .

[4]  Rafael Gozalbes,et al.  Anti-Toxoplasma Activities of 24 Quinolones and Fluoroquinolones In Vitro: Prediction of Activity by Molecular Topology and Virtual Computational Techniques , 2000, Antimicrobial Agents and Chemotherapy.

[5]  Svetlana Markovic,et al.  Spectral Moments of Phenylenes , 2001, J. Chem. Inf. Comput. Sci..

[6]  Ramón García-Domenech,et al.  New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method. , 2003, The Journal of antimicrobial chemotherapy.

[7]  Yovani Marrero-Ponce,et al.  Ligand-Based Virtual Screening and in Silico Design of New Antimalarial Compounds Using Nonstochastic and Stochastic Total and Atom-Type Quadratic Maps , 2005, J. Chem. Inf. Model..

[8]  Milan Randic,et al.  Orthogonal molecular descriptors , 1991 .

[9]  Maykel Pérez González,et al.  Designing Antibacterial Compounds through a Topological Substructural Approach , 2004, J. Chem. Inf. Model..

[10]  Maykel Pérez González,et al.  TOPS-MODE Based QSARs Derived from Heterogeneous Series of Compounds. Applications to the Design of New Herbicides , 2003, J. Chem. Inf. Comput. Sci..

[11]  Yovani Marrero-Ponce,et al.  A linear discrimination analysis based virtual screening of trichomonacidal lead-like compounds: outcomes of in silico studies supported by experimental results. , 2005, Bioorganic & medicinal chemistry letters.

[12]  Alexander Golbraikh,et al.  Novel Chirality Descriptors Derived from Molecular Topology , 2001, J. Chem. Inf. Comput. Sci..

[13]  Milan Randic,et al.  Fitting of nonlinear regressions by orthogonalized power series , 1993, J. Comput. Chem..

[14]  N. Stiefl,et al.  Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique. , 2003, Journal of medicinal chemistry.

[15]  Maykel Cruz-Monteagudo,et al.  QSAR for anti-RNA-virus activity, synthesis, and assay of anti-RSV carbonucleosides given a unified representation of spectral moments, quadratic, and topologic indices. , 2005, Bioorganic & medicinal chemistry letters.

[16]  S. Vilar,et al.  Probabilistic neural network model for the in silico evaluation of anti-HIV activity and mechanism of action. , 2006, Journal of medicinal chemistry.

[17]  Lourdes Santana,et al.  Markovian chemicals “in silico” design (MARCH-INSIDE), a promising approach for computer-aided molecular design III: 2.5D indices for the discovery of antibacterials , 2005 .

[18]  R. Fetterer,et al.  Recent Advances in Biology and Immunobiology of Eimeria Species and in Diagnosis and Control of Infection with These Coccidian Parasites of Poultry , 2002, Clinical Microbiology Reviews.

[19]  J. Gálvez,et al.  Molecular search of new active drugs against Toxoplasma gondii. , 1999, SAR and QSAR in environmental research.

[20]  Maykel Pérez González,et al.  A TOPS-MODE approach to predict adenosine kinase inhibition. , 2004, Bioorganic & medicinal chemistry letters.

[21]  Humberto González Díaz,et al.  Symmetry considerations in Markovian chemicals 'in silico' design (MARCH-INSIDE) I: central chirality codification, classification of ACE inhibitors and prediction of \sigma-receptor antagonist activities , 2003, Comput. Biol. Chem..

[22]  Gurmukh Sahota,et al.  Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations. , 2005, Journal of medicinal chemistry.

[23]  E Estrada,et al.  Novel local (fragment-based) topological molecular descriptors for QSpr/QSAR and molecular design. , 2001, Journal of molecular graphics & modelling.

[24]  Lourdes Santana,et al.  A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins. , 2006, Journal of medicinal chemistry.

[25]  Ramón García-Domenech,et al.  Search of Chemical Scaffolds for Novel Antituberculosis Agents , 2005, Journal of biomolecular screening.

[26]  Lourdes Santana,et al.  3D QSAR Markov model for drug-induced eosinophilia--theoretical prediction and preliminary experimental assay of the antimicrobial drug G1. , 2005, Bioorganic & medicinal chemistry.

[27]  Knut Baumann,et al.  Evaluation of extended parameter sets for the 3D-QSAR technique MaP: Implications for interpretability and model quality exemplified by antimalarially active naphthylisoquinoline alkaloids , 2003, J. Comput. Aided Mol. Des..

[28]  Milan Randic,et al.  Resolution of ambiguities in structure-property studies by use of orthogonal descriptors , 1991, J. Chem. Inf. Comput. Sci..

[29]  Humberto González Díaz,et al.  3D-MEDNEs: an alternative "in silico" technique for chemical research in toxicology. 1. prediction of chemically induced agranulocytosis. , 2003, Chemical research in toxicology.

[30]  Three-dimensional quantitative structure-activity relationship (3D-QSAR) studies of tricyclic oxazolidinones as antibacterial agents. , 2003, Bioorganic & medicinal chemistry.

[31]  Yovani Marrero-Ponce,et al.  3D-chiral Atom, Atom-type, and Total Non-stochastic and Stochastic Molecular Linear Indices and their Applications to Central Chirality Codification , 2005, J. Comput. Aided Mol. Des..

[32]  Francisco Torrens,et al.  3D-chiral quadratic indices of the 'molecular pseudograph's atom adjacency matrix' and their application to central chirality codification: classification of ACE inhibitors and prediction of sigma-receptor antagonist activities. , 2004, Bioorganic & medicinal chemistry.

[33]  Knut Baumann,et al.  Structure-Based Validation of the 3D-QSAR Technique MaP , 2005, J. Chem. Inf. Model..

[34]  Maykel Pérez González,et al.  TOPS-MODE versus DRAGON descriptors to predict permeability coefficients through low-density polyethylene , 2003, J. Comput. Aided Mol. Des..

[35]  S. Eriksson,et al.  Comparative molecular field analysis and comparative molecular similarity indices analysis of human thymidine kinase 1 substrates. , 2005, Bioorganic & medicinal chemistry.

[36]  Maykel Cruz-Monteagudo,et al.  Predicting multiple drugs side effects with a general drug-target interaction thermodynamic Markov model. , 2005, Bioorganic & medicinal chemistry.

[37]  Miguel A. Cabrera,et al.  Markovian chemicals "in silico" design (MARCH-INSIDE), a promising approach for computer-aided molecular design I: discovery of anticancer compounds , 2003, Journal of molecular modeling.

[38]  Humberto González Díaz,et al.  Simple stochastic fingerprints towards mathematical modelling in biology and medicine. 1. The treatment of coccidiosis , 2004, Bulletin of mathematical biology.

[39]  Francisco Torrens,et al.  Atom, atom-type and total molecular linear indices as a promising approach for bioorganic and medicinal chemistry: theoretical and experimental assessment of a novel method for virtual screening and rational design of new lead anthelmintic. , 2005, Bioorganic & medicinal chemistry.

[40]  Eduardo A. Castro,et al.  Tomocomd-Cardd, a novel approach for computer-aided ‘ rational’ drug design: I. Theoretical and experimental assessment of a promising method for computational screening and in silico design of new anthelmintic compounds , 2004, J. Comput. Aided Mol. Des..

[41]  Humberto González-Díaz,et al.  Biopolymer stochastic moments. I. Modeling human rhinovirus cellular recognition with protein surface electrostatic moments , 2005, Biopolymers.

[42]  Anton J. Hopfinger,et al.  A 3D-QSAR Study of Anticoccidial Triazines Using Molecular Shape Analysis , 1995, J. Chem. Inf. Comput. Sci..

[43]  Lourdes Santana,et al.  Design, synthesis and photobiological properties of 3,4-cyclopentenepsoralens. , 2005, Bioorganic & medicinal chemistry.

[44]  Maykel Cruz-Monteagudo,et al.  Unified drug-target interaction thermodynamic Markov model using stochastic entropies to predict multiple drugs side effects. , 2005, European journal of medicinal chemistry.

[45]  V. Kulkarni,et al.  Three-dimensional quantitative structure-activity relationship (3D-QSAR) of 3-aryloxazolidin-2-one antibacterials. , 2001, Bioorganic & medicinal chemistry.

[46]  Maykel Pérez González,et al.  A topological substructural approach applied to the computational prediction of rodent carcinogenicity. , 2005, Bioorganic & medicinal chemistry.